Literature DB >> 20674184

Do cytokines induce vascular calcification by the mere stimulation of TNAP activity?

P Lencel1, P Hardouin, D Magne.   

Abstract

Vascular calcification occurs during aging in the general population and is increased in the intima by atherosclerosis and in the media by diabetes type 2. In both intima and media, calcification may lead to the formation of a tissue very similar if not identical to bone, with bone cells and bone marrow. Since vascular calcification is associated with cardiovascular complications, a better understanding of the inducing mechanisms could lead to the development of new therapeutic strategies. Many studies have provided evidence for a role of inflammation and inflammatory cytokines such as tumour necrosis factor (TNF)-α and interleukin (IL)-1β in the vascular calcification process. TNF-α and IL-1β have indeed been shown to stimulate in vitro the expression by vascular smooth muscle cells (VSMCs) of tissue-non specific alkaline phosphatase (TNAP), a key enzyme in the mineralization process, and to trigger the trans-differentiation of VSMCs into osteoblast-like cells, expressing the master transcription factor RUNX2. These data are however somewhat contradictory with the known inhibitory effects of inflammatory cytokines on bone formation. TNF-α for instance dramatically decreases RUNX2 RNA expression, protein stability and activity, and as a consequence, is a potent inhibitor of osteoblast differentiation and bone formation. In the present article, we propose a new hypothesis to explain this calcification paradox. We propose that cytokines block bone formation by decreasing RUNX2-mediated type I collagen production in osteoblasts, whereas they induce vascular ossification by the mere stimulation of TNAP by VSMCs, independently of RUNX2. We propose that this stimulation of TNAP in VSMCs in vitro and in vivo may be sufficient to induce the calcification of collagen fibrils, and that the absence of crystal clearance, in turn, induces the differentiation of VSMCs and/or mesenchymal stem cells into bone-forming cells, eventually leading to formation of a bone-like tissue. In case future experimental studies support this hypothesis, the early stimulatory and late inhibitory effects of inflammation on vascular calcification will have to be taken into consideration in the development of new therapeutic strategies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674184     DOI: 10.1016/j.mehy.2010.07.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.

Authors:  H Huang; N Zhao; X Xu; Y Xu; S Li; J Zhang; P Yang
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

Review 2.  The role of the gasotransmitter hydrogen sulfide in pathological calcification.

Authors:  Mariela Castelblanco; Sonia Nasi; Andreas Pasch; Alexander So; Nathalie Busso
Journal:  Br J Pharmacol       Date:  2019-07-24       Impact factor: 8.739

3.  High dose of TNF-α suppressed osteogenic differentiation of human dental pulp stem cells by activating the Wnt/β-catenin signaling.

Authors:  Zhenjie Qin; Zhixiu Fang; Lei Zhao; Jing Chen; Yuanteng Li; Guangyun Liu
Journal:  J Mol Histol       Date:  2015-06-27       Impact factor: 2.611

4.  P2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vessels.

Authors:  Maria Lombardi; Maria Elena Mantione; Domenico Baccellieri; David Ferrara; Renata Castellano; Roberto Chiesa; Ottavio Alfieri; Chiara Foglieni
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

5.  Infection of Porphyromonas gingivalis Increases Phosphate-Induced Calcification of Vascular Smooth Muscle Cells.

Authors:  Hyun-Joo Park; Yeon Kim; Mi-Kyoung Kim; Hae-Ryoun Park; Hyung-Joon Kim; Soo-Kyung Bae; Moon-Kyoung Bae
Journal:  Cells       Date:  2020-12-15       Impact factor: 6.600

6.  Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification.

Authors:  Takeshi Tanaka; Takaharu Asano; Takehito Okui; Shiori Kuraoka; Sasha A Singh; Masanori Aikawa; Elena Aikawa
Journal:  Front Cardiovasc Med       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.